Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665.
N Engl J Med. 2021.
PMID: 34437784
Free PMC article.
Clinical Trial.
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group.
Flume PA, et al.
Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10.
Lancet Respir Med. 2021.
PMID: 33581080
Item in Clipboard
Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations.
McBennett KA, Davis PB.
McBennett KA, et al.
Clin Chest Med. 2022 Dec;43(4):579-590. doi: 10.1016/j.ccm.2022.06.002.
Clin Chest Med. 2022.
PMID: 36344067
Review.
Item in Clipboard
Increasing life expectancy in cystic fibrosis: Advances and challenges.
McBennett KA, Davis PB, Konstan MW.
McBennett KA, et al.
Pediatr Pulmonol. 2022 Feb;57 Suppl 1(Suppl 1):S5-S12. doi: 10.1002/ppul.25733. Epub 2021 Nov 11.
Pediatr Pulmonol. 2022.
PMID: 34672432
Free PMC article.
Review.
Item in Clipboard
Cite
Cite